Results 1 - 20 of 1,439 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (1,398)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19International Journal of Antimicrobial Agents, 2020-04 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.ijantimicag.2020.105932Digital Resources/Online E-Resources |
| 2 |
Material Type: Article
|
|
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analysesThe Lancet (British edition), 2022-05, Vol.399 (10339), p.1941-1953 [Peer Reviewed Journal]2022 World Health Organization ;2022 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;info:eu-repo/semantics/openAccess ;2022 World Health Organization 2022 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00519-0 ;PMID: 35512728Full text available |
| 3 |
Material Type: Article
|
|
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsNew England Journal of Medicine, 2021-02, Vol.384 (6), p.497-511 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2023184 ;PMID: 33264556Digital Resources/Online E-Resources |
| 4 |
Material Type: Article
|
|
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19New England Journal of Medicine, 2020-11, Vol.383 (19), p.1827-1837 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2015301 ;PMID: 32459919Digital Resources/Online E-Resources |
| 5 |
Material Type: Article
|
|
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell research, 2020-03, Vol.30 (3), p.269-271 [Peer Reviewed Journal]This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-020-0282-0 ;PMID: 32020029Full text available |
| 6 |
Material Type: Article
|
|
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020-01, Vol.11 (1), p.222-14, Article 222 [Peer Reviewed Journal]This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-13940-6 ;PMID: 31924756Digital Resources/Online E-Resources |
| 7 |
Material Type: Article
|
|
Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020-11, Vol.383 (19), p.1813-1826 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2007764 ;PMID: 32445440Digital Resources/Online E-Resources |
| 8 |
Material Type: Article
|
|
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infectionProceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (12), p.6771-6776 [Peer Reviewed Journal]Copyright National Academy of Sciences Mar 24, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1922083117 ;PMID: 32054787Full text available |
| 9 |
Material Type: Article
|
|
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potencyThe Journal of biological chemistry, 2020-05, Vol.295 (20), p.6785-6797 [Peer Reviewed Journal]2020 © 2020 Gordon et al. ;2020 Gordon et al. ;2020 Gordon et al. 2020 Gordon et al. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.RA120.013679 ;PMID: 32284326Full text available |
| 10 |
Material Type: Article
|
|
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19New England Journal of Medicine, 2021-03, Vol.384 (9), p.795-807 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2031994 ;PMID: 33306283Digital Resources/Online E-Resources |
| 11 |
Material Type: Article
|
|
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020-05, Vol.395 (10236), p.1569-1578 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31022-9 ;PMID: 32423584Digital Resources/Online E-Resources |
| 12 |
Material Type: Article
|
|
Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsNew England Journal of Medicine, 2022-01, Vol.386 (4), p.305-315 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116846 ;PMID: 34937145Digital Resources/Online E-Resources |
| 13 |
Material Type: Article
|
|
Understanding of COVID‐19 based on current evidenceJournal of Medical Virology, 2020-06, Vol.92 (6) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25722Digital Resources/Online E-Resources |
| 14 |
Material Type: Article
|
|
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A ReviewJAMA, 2020-05, Vol.323 (18), p.1824 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.6019Digital Resources/Online E-Resources |
| 15 |
Material Type: Article
|
|
Severe Covid-19New England Journal of Medicine, 2020-12, Vol.383 (25), p.2451-2460 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcp2009575 ;PMID: 32412710Digital Resources/Online E-Resources |
| 16 |
Material Type: Article
|
|
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical TrialJAMA, 2020-09, Vol.324 (11), p.1048 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.16349Digital Resources/Online E-Resources |
| 17 |
Material Type: Article
|
|
Structure of the RNA-dependent RNA polymerase from COVID-19 virusScience, 2020-05, Vol.368 (6492) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abb7498Digital Resources/Online E-Resources |
| 18 |
Material Type: Article
|
|
Mechanism of SARS-CoV-2 polymerase stalling by remdesivirNature communications, 2021-01, Vol.12 (1), p.279-7, Article 279 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20542-0 ;PMID: 33436624Full text available |
| 19 |
Material Type: Article
|
|
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of CareClinical infectious diseases, 2021-12, Vol.73 (11), p.e4166-e4174 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1041 ;PMID: 32706859Full text available |
| 20 |
Material Type: Article
|
|
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19New England Journal of Medicine, 2021-03, Vol.384 (10), p.905-914 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2033130 ;PMID: 33356051Digital Resources/Online E-Resources |
Results 1 - 20 of 1,439 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (1,398)
Refine My Results
Creation Date
- Before 1976 (49)
- 1976 To 1987 (219)
- 1988 To 1999 (218)
- 2000 To 2012 (261)
- After 2012 (693)
-
More options
New Records
Subject
- Adenosine Monophosphate - Analogs & Derivatives (1,269)
- Science & Technology (1,157)
- Life Sciences & Biomedicine (1,057)
- Humans (825)
- Alanine - Analogs & Derivatives (525)
- Animals (427)
- Covid-19 (410)
- Biochemistry & Molecular Biology (342)
- Sars-Cov-2 (333)
- Adenosine Monophosphate - Therapeutic Use (331)
- Adenosine Monophosphate - Pharmacology (317)
- Alanine - Therapeutic Use (258)
- Male (256)
- Antiviral Agents - Therapeutic Use (251)
- Coronaviruses (242)
- Pandemics (222)
- Female (218)
- Biological And Medical Sciences (212)
- Adenosine Monophosphate - Metabolism (207)
- Covid-19 - Drug Therapy (205)
-
More options
Databases
- MEDLINE (1,437)
- GFMER Free Medical Journals (634)
- ProQuest Central (536)
- PubMed Central (481)
- DOAJ Directory of Open Access Journals (380)
- HighWire Press (Free Journals) (289)
- ROAD: Directory of Open Access Scholarly Resources (205)
- Coronavirus Research Database (186)
- Wiley-Blackwell Open Access Titles (134)
- ProQuest One Psychology (84)
- Springer Nature OA/Free Journals (48)
- Nature Open Access (41)
- Oxford Journals Open Access Collection (39)
- JSTOR Early Journal Content (35)
- IngentaConnect Free/Open Access Journals (28)
- Public Library of Science (PLoS) (26)
- Cell Press Free Archives (19)
- Hyper Article en Ligne (HAL) (Open Access) (19)
- Journals@Ovid Open Access Journal Collection Rolling (17)
- SAGE Open Access Journals (14)
-
More options
Language
- English (1,434)
- Japanese (185)
- Portuguese (3)
- French (3)
- Norwegian (2)
- Chinese (1)
- Turkish (1)
- Spanish (1)
-
More options
Journal Title
- Biochemical And Biophysical Research Communications (17)
- Biochemistry (63)
- European Journal Of Biochemistry (22)
- Febs Letters (34)
- Nature (23)
- Nucleic Acids Research (25)
- Plos One (21)
- Proceedings Of The National Academy Of Sciences - Pnas (23)
- The Journal Of Biological Chemistry (72)
- The New England Journal Of Medicine (36)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||